BioMidwest
Filter News
Found 78,736 articles
-
As BioSpace proudly introduces our 2022 Hotbed Maps, let’s explore the industry’s most thriving territories, research leading employers and search for relevant jobs on BioSpace. -
Life Biosciences and Forge Biologics Announce cGMP Manufacturing Partnership to Advance Development of Novel Gene Therapies for Aging-Related Diseases
5/8/2023
Life Biosciences and Forge Biologics today announced a manufacturing partnership to help advance Life Bio’s partial epigenetic reprogramming platform to address aging-related diseases, including its lead program targeting ophthalmic indications.
-
Pulmonary Fibrosis Foundation Urges Patients to Use Only FDA-Approved Oxygen Delivery Devices
5/8/2023
The medical advisory board of the Pulmonary Fibrosis Foundation (PFF), the nation's leading pulmonary fibrosis (PF) research, education, and advocacy organization, has issued a position statement on non-prescription supplemental oxygen.
-
SomaLogic opens their first-ever proteomics grant program to APAC life sciences researchers
5/8/2023
SomaLogic, Inc., a global leader in proteomics technology, announced that it is sponsoring the Genomax Research Grant Award for researchers in Singapore.
-
Zomedica Exercises Option to Acquire Structured Monitoring Products
5/8/2023
Zomedica Corp., announced it has exercised its option to move forward with the acquisition of Structured Monitoring Products, Inc., the makers of VetGuardian™ zero-touch vital signs remote monitoring system, at a previously negotiated purchase price.
-
HAPPE Spine Announces FDA Clearance for the INTEGRATE-C™ Interbody Fusion System
5/8/2023
HAPPE Spine announces that the company's INTEGRATE-C™ Interbody Fusion System has received 510k clearance from the FDA.
-
ANI Pharmaceuticals Reports Record First Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance
5/8/2023
ANI Pharmaceuticals, Inc. announced business highlights and financial results for the three months ended March 31, 2023.
-
DiaMedica Therapeutics to Report First Quarter 2023 Financial Results and Provide a Business Update May 16, 2023
5/8/2023
DiaMedica Therapeutics Inc. announced today that its first quarter 2023 financial results will be released after the markets close on Monday, May 15th.
-
Celcuity to Present Updated Results for Treatment-Naïve Patients from Phase 1b Study of Gedatolisib at the 2023 ESMO Breast Cancer Annual Congress
5/8/2023
Celcuity Inc. today announced publication of an abstract reporting updated results for treatment-naive patients from the Phase 1b study of gedatolisib, a pan-PI3K/mTOR inhibitor, in combination with palbociclib and letrozole in women with HR+/HER2- advanced breast cancer (ABC).
-
Quipt Home Medical Announces Date and Time for Fiscal Q2 2023 Conference Call and Audio Webcast
5/8/2023
Quipt Home Medical Corp. today announced that it will host its Fiscal Q2 2023 earnings conference call and audio webcast on Tuesday, May 16, 2023 at 10:00 a.m. (ET).
-
Predictive Oncology to Report First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 15, 2023
5/8/2023
Predictive Oncology Inc. (NASDAQ: POAI) today announced that it will report its financial results for the first quarter ended March 31, 2023 after the market close on Monday, May 15, 2023.
-
MAIA Biotechnology Reports First Quarter 2023 Financial Results and Provides Corporate Update
5/8/2023
MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today reported financial results for the first quarter ended March 31, 2023, and provided a corporate update.
-
AbbVie Releases New Data Demonstrating Breadth of Its Gastroenterology Portfolio at 2023 Digestive Disease Week®
5/6/2023
AbbVie announced it will present 29 abstracts during the 2023 Digestive Disease Week Annual Meeting, May 6-9, 2023, being held in Chicago and virtually.
-
ABRF 2023 Annual Meeting, May 7-10, Boston
5/5/2023
The Association of Biomolecular Resource Facilities 2023 Annual Meeting will be held May 7-10 at the Sheraton Boston Hotel.
-
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
5/5/2023
NeuroOne Medical Technologies today announced that, effective May 1, 2023, the Compensation Committee of the Board of Directors approved an equity award under the NeuroOne Medical Technologies Corporation 2021 Inducement Plan.
-
VolitionRx Limited Schedules First Quarter 2023 Earnings Conference Call and Business Update
5/5/2023
VolitionRx Limited announced it will host a conference call on Thursday May 11 at 08.30 a.m. Eastern Time to discuss its financial and operating results for the first quarter 2023, in addition to providing a business update.
-
Heska Corporation Reports First Quarter 2023 Results
5/5/2023
Heska Corporation, a leading global provider of advanced veterinary diagnostic and specialty products, reported financial results for its first quarter ended March 31, 2023.
-
Assertio Holdings, Inc. Updates First Quarter 2023 Financial Results Call Time to Tuesday, May 9, 2023 at 11:30 am Eastern Time
5/5/2023
Assertio Holdings, Inc., a specialty pharmaceutical company offering differentiated products to patients, announced that it will release first quarter 2023 financial results on Tuesday, May 9, 2023, before the market open.
-
AACE Releases 2023 Type 2 Diabetes Management Algorithm to Support Clinical Decision Making
5/5/2023
The American Association of Clinical Endocrinology announced the publication of the 2023 Comprehensive Type 2 Diabetes Management Algorithm, which provides concise guidance to assist healthcare professionals in clinical decision-making for the management of Type 2 diabetes.
-
Nexus Pharmaceuticals, Inc. Receives Successful FDA Inspection of Pharmaceutical Manufacturing Facility in Pleasant Prairie, Wisconsin
5/5/2023
Nexus Pharmaceuticals, Inc. announced that its pharmaceutical manufacturing facility in Pleasant Prairie, Wisconsin, was successfully inspected by the Food and Drug Administration, which will allow Nexus to begin commercial operations.